Pharmacist Digest

STAT+: Illumina to lay off 10% of research and development team in bid to cut costs by $100 million

STAT

JUNE 26, 2023

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT. Barnard’s note mentions that all affected employees have already been notified.

Viatris and Idorsia enter research and development collaboration

Pharmafile

FEBRUARY 28, 2024

Viatris and Idorsia have announced that they have entered into agreements for a significant global research and development collaboration. Assets included in […] The post Viatris and Idorsia enter research and development collaboration appeared first on Pharmafile.

IRA Impacts: Cancer treatment research and development

PhRMA

MARCH 23, 2023

Much of the positive trends in declining cancer mortality, down 33% since peaking in 1991, is driven in large part by innovative medicines researched and developed by America’s biopharmaceutical companies. But more needs to be done.

Rankings: Research and Development

Pharmaceutical Technology

NOVEMBER 1, 2022

What is Research and Development (R&D)? This category includes organisations that have demonstrated a commitment to the research and development of new products and/or new processes. This category highlights companies that have conducted research into the use of AI and technology for the development of new treatments.

Vaccines

Vaccines Drug Development

Deep Dive: Research and Development 2024

pharmaphorum

MARCH 1, 2024

Gain insights into the research and development strategies of leading companies like Alexion, Samsung Biologics, JPM, UCB, and Clinigen with in-depth interviews and analysis for 2024.

STAT+: A new list ranks large pharmaceutical companies by research and development

STAT

MAY 4, 2023

If you want a large pharmaceutical company to invent a new drug, your best bet is probably AstraZeneca. But if you have a medicine you’d like to get to market — and you want to see it generate revenue — you might be better off with Pfizer.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Pilot to support ATMP research and development

European Pharmaceutical Review

OCTOBER 4, 2022

The chosen organisations will be assisted through the regulatory process, from best manufacturing practice to planning regulation-approved clinical development. The pilot will focus on the needs of non-profit academic developers. The pilot will focus on the needs of non-profit academic developers.

Hospitals

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. Human-first precision health.

Immunity

Immunity Immunization Drug Development

Bayer and Broad Institute of MIT and Harvard extend research collaboration to develop new cancer therapies

World Pharma News

NOVEMBER 2, 2023

Bayer and the Broad Institute of MIT and Harvard today announced that they have extended their research collaboration of 10 years by an additional five years, to develop and advance innovative cancer treatments.

Avistone raises $140m to support drug research and development

Pharmaceutical Technology

JANUARY 5, 2024

Avistone has closed its Series B financing round, raising 1bn yuan ($140m), to support clinical research and development of its drug pipeline.

Pfizer announces executive leadership to advance oncology research and development strategy

World Pharma News

JULY 27, 2023

(NYSE: PFE) today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with an emphasis on oncology. PhD, will join Pfizer's Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to

Vaccines

Daiichi Sankyo to close Japanese research and development subsidiary

Pharmaceutical Business Review

AUGUST 7, 2023

With advanced research technology infrastructure and clinical development capability, RD Novare plays a role in the R&D of Daiichi Sankyo group of companies by contributing to new pharmaceuticals creation. In the end of March next year, it is claimed to complete its business as a corporate entity.

BMS shares new research and development plans at the company’s R&D day

Pharmafile

SEPTEMBER 15, 2023

Bristol Myers Squibb (BMS) recently held a Research and Development (R&D) Day in New York, US, in order to discuss the company’s R&D strategy and capabilities while providing insights into its pipeline and long-term growth plans.

STAT+: Alzheimer’s risk gene APOE4 may cause a distinct form of the disease, study suggests

STAT

MAY 6, 2024

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant.

Deep Dive: Research and Development

pharmaphorum

FEBRUARY 24, 2022

Fuelled by advancements in technology and computing, R&D in life sciences is undergoing a fundamental transformation that puts patients at the heart of research. Inside the changing tides of life science research. Astellas Pharma’s Bernie Zeiher discusses the changing nature of life science research.

Communication

Communication Pharmaceutical Companies Pharmaceutical Companies

STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint

STAT

MARCH 22, 2024

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday. “Time is life. You care about patients.

Drug Development

Drug Development Vaccines

Deep Dive: Research and Development

pharmaphorum

FEBRUARY 26, 2021

Inside the UK’s leading efforts to restart clinical research. Experts from the institute tell us how lessons learned from the sector-wide collaboration will change UK research forever. The post-COVID face of pharma research and development. Solving the “information challenge” of rare disease diagnosis.

Vaccines

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies